Role of omentin and chemerin in metabolic syndrome and tumor diseases;Rola omentyny i chemeryny w zespole metabolicznym i chorobach nowotworowych

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 70, Issue , 2016, Pages 844-849

  Szydło, Błazej ^a   Kiczmer, Paweł ^a   Świȩtochowska, Elzbieta ^a   Ostrowska, Zofia ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Chemerin; Metabolic syndrome; Omentin; Tumor diseases

Indexed keywords

BIOLOGICAL MARKER; CHEMERIN PROTEIN, HUMAN; CHEMOKINE; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; INSULIN; ITLN1 PROTEIN, HUMAN; LECTIN; SIGNAL PEPTIDE;

BLOOD; HUMAN; METABOLIC SYNDROME X; METABOLISM; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY;

BIOMARKERS; CHEMOKINES; CYTOKINES; DIABETES MELLITUS, TYPE 2; GPI-LINKED PROTEINS; HUMANS; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LECTINS; METABOLIC SYNDROME X; NEOPLASMS; OBESITY;

EID: 85015681818     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.1214137     Document Type: Review

References (37)

1. Aktas G., Alcelik A., Ozlu T., Tosun M., Tekce B.K., Savli H., Tekce A., Dikbas O.: Association between omentin levels and insulin resistance in pregnancy Exp Clin Endocrinol Diabetes, 2014; 122: 163-166
2. Bozaoglu K., Bolton K., McMillan J., Zimmet P., Jowett J., Collier G., Walder K., Segal D.: Chemerin is a novel adipokine associated with obesity and metabolic syndrome Endocrinology, 2007; 148: 4687-4694
3. Bozaoglu K., Curran J.E., Stocker C.J., Zaibi M.S., Segal D., Konstantopoulos N., Morrison S., Carless M., Dver T.D., Cole S.A., Goring H.H., Moses E.K., Walder K., Cawthorne M.A., Blangero J i wsp.: Chemerin, a novel adipokine in the regulation of angiogenesis J Clin Endocrinol Metab., 2010; 95: 2476-2485
4. Bozaoglu K., Segal D., Shields K.A., Cummings N., Curran J.E., Comuzzie A.G., Mahaney M.C., Rainwater D.L., WandenBerg J.L., MacCluer J.W., Collier G., Blangero J., Walser K., Jovett J.B.: Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population J Clin Endocrinol Metab., 2009; 94: 3085-3088
5. Brunetti L., Leone S., Orlando G., Ferrante C., Recinella L., Chiavaroli A., Di Nisio C., Shohreh R., Manippa F., Ricciuti A., Vacca M.: Hypotensive effects of omentin-1 related to increased adiponectin and decreased interleukin-6 in intra-thoracic pericardial adipose tissue Pharmacol Rep., 2014; 66: 991-995
6. Chakaroun R., Raschpichler M., Klöting N., Oberbach A., Flehmig G., Kern M., Shön M.R., Shang E., Lohmann T., Dreler M., Fasshauer M., Stumvoll M., Blüher M.: Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity Metabolism, 2012; 61: 706-714
7. de Souza Batista C.M., Yang R.Z., Lee M.J., Glynn N.M., Yu D.Z., Pray J., Ndubuizu K., Patil S., Schwartz A., Kligman M., Fried SK., Gong DW., Shuldiner A.R., Pollin T.I., McLenithan J.C.: Omentin plasma levels and gene expression are decreased in obesity Diabetes, 2007; 56: 1655-1661
8. Fatima S.S., Bozaoglu K., Rehman R., Alam F., Memon A.S.: Elevated chemerin levels in Pakistani men: an interrelation with metabolic syndrome phenotypes PLoS One, 2013; 8: e57113
9. Fazeli M.S., Dashti H., Akbarzadeh S., Assadi M., Aminian A., Keramati M.R., Nabipour I.: Circulating levels of novel adipocytokines in patients with colorectal cancer Cytokine, 2013; 62: 81-85
10. Fernandez-Ranvier G.G., Weng J., Yeh R.F., Khanafshar E., Suh I., Barker C., Duh Q.Y., Clark O.H., Kebebew E.: Identification of biomarkers of adrenocortical carcinoma using genomewide gene expression profiling Arch Surg., 2008; 143: 841-846
11. Goralski K.B., McCarthy T.C., Hanniman E.A., Zabel B.A., Butcher E.C., Parlee S.D., Muruganandan S., Sinal C.J.: Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism J Biol Chem., 2007; 282: 28175-28188
12. Guzel E.C., Celik C., Abali R., Kucukyalcin V., Celik E., Guzel M., Yilmaz M.: Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome Gynecol Endocrinol., 2014; 30: 419-422
13. Hah Y.J., Kim N.K., Kim M.K., Kim H.S, Hur S.H., Yoon H.J., Kim Y.N., Park K.G.: Relationship between chemerin levels and cardiometabolic parameters and degree of coronary stenosis in Korean patients with coronary artery disease Diabetes Metab J., 2011; 35: 248-254
14. Kataoka Y., Shibata R., Ohashi K., Kambara T., Enomoto T., Uemura Y., Oqura Y., Yuasa D., Matsuo K., Nagata T., Oba T., Yasukawa H., Numaquchi Y., Sone T., Murohara T i wsp.: Omentin prevents myocardial ischemic injury through AMP-Activated protein kinase-And Akt-dependent mechanisms J Am Coll Cardiol., 2014; 63: 2722-2733
15. Lapointe M., Poirier P., Martin J., Bastien M., Auclair A., Cianflone K.: Omentin changes following bariatric surgery and predictive links with biomarkers for risk of cardiovascular disease Cardiovasc Diabetol., 2014; 13: 124
16. Liu R., Wang X., Bu P.: Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome Diabetes Res Clin Pract., 2011; 93: 21-25
17. Mohr S., Bottin M.C., Lannes B., Neuville A., Bellocq J.P., Keith G., Rihn B.H.: Microdissection, mRNA amplification and microarray: a study of pleural mesothelial and malignant mesothelioma cells Biochimie, 2004; 86: 13-19
18. Moreno-Navarrete J.M., Catalán V., Ortega F., Gómez-Ambrosi J., Ricart W., Frühbeck G., Fernández-Real J.M.: Circulating omentin concentration increases after weight loss Nutr Metab., 2010; 7: 27
19. Nagpal S., Patel S., Jacobe H., DiSepio D., Ghosn C., Malhotra M Teng M., Duvic M., Chandraratna R.A.: Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin J Invest Dermatol., 1997; 109: 91-95
20. Niedzwiedzka-Rystwej P., Trzeciak-Ryczek A., Deptula W.: Tkanka tluszczowa i jej rola w odpornosci-nowe dane Alergia Astma Immunologia, 2012, 17: 16-21
21. Onur I., Oz F., Yildiz S., Kuplay H., Yucel C., Sigirci S., Elitok A., Piten S., Kasali K., Yasar Cizgici A., Erentug V., Dinckal H.M.: A decreased serum omentin-1 level may be an independent risk factor for peripheral arterial disease Int Angiol., 2014; 33: 455-460
22. Park I.H., Park S.J., Cho J.S., Moon Y.M., Kim T.H., Lee S.H., Lee H.M.: Increased expression of intelectin-1 in nasal polyps Am J Rhinol Allergy, 2012; 26: 274-277
23. Saremi A., Asghari M., Ghorbani A.: Effects of aerobic training on serum omentin-1 and cardiometabolic risk factors in overweight and obese men J Sports Sci., 2010; 28: 993-998
24. Sell H., Divoux A., Poitou C., Basdevant A., Bouillot J.L., Bedossa P., Tordjman J., Eckel J., Clément K.: Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery J Clin Endocrinol Metab., 2010; 95: 2892-2896
25. Stejskal D., Karpisek M., Hanulova Z., Svestak M.: Chemerin is an independent marker of the metabolic syndrome in a Caucasian population-A pilot study Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub., 2008; 152: 217-221
26. Tan B.K., Adya R., Randeva H.S.: Omentin: a novel link between inflammation, diabesity, and cardiovascular disease Trends Cardiovasc Med., 2010; 20: 143-148
27. Uemura Y., Shibata R., Kanemura N., Ohashi K., Kambara T., Hiramatsu-Ito M., Enomoto T., Yuasa D., Joki Y., Matsuo K., Ito M., Hayakawa S., Oqawa H., Murohara T., Ouchi N.: Adipose-derived protein omentin prevents neointimal formation after arterial injury FASEB J., 2015; 29: 141-151
28. Uyeturk U., Sarici H., Kin T.B., Eroglu M., Kemahli E., Uyeturk U., Gucuk A.: Serum omentin level in patients with prostate cancer Med Oncol., 2014; 31: 923
29. Washimi K., Yokose T., Yamashita M., Kageyama T., Suzuki K., Yoshihara M., Miyagi Y., Hayashi H., Tsuji S.: Specific expression of human intelectin-1 in malignant pleural mesothelioma and gastrointestinal goblet cells PLoS One, 2012; 7: e39889
30. Wójcik M., Chmielewska-Kassassir M., Grzywnowicz K., Wozniak L., Cypryk K.: The relationship between adipose tissue-derived hormones and gestational diabetes mellitus (GDM) Endokrynol Pol., 2014; 65: 134-142
31. Wu S.S., Liang Q.H., Liu Y., Cui R.R., Yuan L.Q., Liao E.Y.: Omentin-1 stimulates human osteoblast proliferation through PI3K/Akt signal pathway Int J Endocrinol., 2013; 2013: 368970
32. Yamawaki H., Tsubaki N., Mukohda M., Okada M., Hara Y.: Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels Biochem Biophys Res Commun., 2010; 393: 668-672
33. Yan P., Liu D., Long M., Ren Y., Pang J., Li R.: Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus Exp Clin Endocrinol Diabetes, 2011; 119: 257-263
34. Zhang J., Jin H.C., Zhu A.K., Ying R.C., Wei W., Zhang F.J.: Prognostic significance of plasma chemerin levels in patients with gastric cancer Peptides, 2014; 61: 7-11
35. Zhang Q., Zhu L., Zheng M., Fan C., Li Y., Zhang D., He Y., Yang H.: Changes of serum omentin-1 levels in normal subjects, type 2 diabetes and type 2 diabetes with overweight and obesity in Chinese adults Ann Endocrinol., 2014; 75: 171-175
36. Zhang Y.Y., Zhou L.M.: Omentin-1, a new adipokine, promotes apoptosis through regulating Sirt1-dependent p53 deacetylation in hepatocellular carcinoma cells Eur J Pharmacol., 2013; 698: 137-144
37. Zhong X., Li X., Liu F., Tan H., Shang D.: Omentin inhibits TNF-A-induced expression of adhesion molecules in endothelial cells via ERK/NF-?B pathway Biochem Biophys Res Commun., 2012; 425: 401-406